Leaflet METOPIRONE 250mg soft capsules
Product code: W71299001 Quantity: 50
Indicated for: endogenous Cushing syndrome
Route of administration: oral
Substance: metirapone (steroidogenesis inhibitor)
ATC: V04CD01 (Various | Other diagnostic agents | Tests for pituitary function)
Metyrapone is a cortisol synthesis inhibitor used for the diagnosis of adrenal insufficiency and the treatment of Cushing's syndrome. It works by inhibiting the enzyme 11-beta-hydroxylase, reducing cortisol production.
The medication is taken orally, usually in divided doses, with the dose adjusted based on the patient's response and hormone levels. Common side effects include nausea, vomiting, abdominal pain, and dizziness.
Metyrapone is contraindicated in patients with hypersensitivity to the active substance or severe hepatic impairment. Its use also requires careful monitoring of adrenal function and blood pressure.
This medication is an important option for diagnosing and managing adrenal disorders, helping to improve patients' quality of life.
General data about METOPIRONE 250mg
- Substance: metirapone
- Date of latest medicines list: 01-06-2026
- Product code: W71299001
- Concentration: 250mg
- Pharmaceutical form: soft capsules
- Quantity: 50
- Product type: Generic medicine
- Price: 1299.28 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.